{"date":"2025-08-22","count":22,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6885-2025-08-22-1919-11drzab","company_id":"6885","company":"全福生技","market":"上市","industry":"生技醫療","date":"2025-08-22","time":"19:19:20","subject":"公告本公司114年8月26日受邀參加國票證券舉辦之法人說明會，說明公司營運概況及未來展望。","clause":"第12款","fact_date":"2025-08-26","cite_as":"公開資訊觀測站重大訊息：全福生技（6885），2025-08-22 19:19，「公告本公司114年8月26日受邀參加國票證券舉辦之法人說明會，說明公司營運概況及未來展望。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-08-22-1743-hw20yg","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-08-22","time":"17:43:31","subject":"合一ON101乳膏有效治療Wagner 2-3級困難癒合糖尿病足潰瘍病例研究，於國際SCI期刊Journal of Wound Care發表","clause":"第53款","fact_date":"2025-08-22","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-08-22 17:43，「合一ON101乳膏有效治療Wagner 2-3級困難癒合糖尿病足潰瘍病例研究，於國際SCI期刊Journal of Wo」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4138-2025-08-22-1713-1kbupvl","company_id":"4138","company":"曜亞","market":"上櫃","industry":"生技醫療","date":"2025-08-22","time":"17:13:44","subject":"公告修正本公司113年度股東會年報部分內容","clause":"第50款","fact_date":"2025-08-22","cite_as":"公開資訊觀測站重大訊息：曜亞（4138），2025-08-22 17:13，「公告修正本公司113年度股東會年報部分內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2025-08-22-1711-tzmide","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2025-08-22","time":"17:11:18","subject":"代重要子公司台灣泰福生技股份有限公司公告新任董事長","clause":"第6款","fact_date":"2025-08-22","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2025-08-22 17:11，「代重要子公司台灣泰福生技股份有限公司公告新任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2025-08-22-1710-ksbtem","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2025-08-22","time":"17:10:49","subject":"本公司註銷限制員工權利新股變更登記完成","clause":"第35款","fact_date":"2025-08-22","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2025-08-22 17:10，「本公司註銷限制員工權利新股變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2025-08-22-1710-1mlguiz","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2025-08-22","time":"17:10:01","subject":"代重要子公司台灣泰福生技股份有限公司公告法人董事改派代表人暨三分之一以上董事異動","clause":"第6款","fact_date":"2025-08-22","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2025-08-22 17:10，「代重要子公司台灣泰福生技股份有限公司公告法人董事改派代表人暨三分之一以上董事異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2025-08-22-1705-1lmv9jb","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2025-08-22","time":"17:05:31","subject":"公告補正本公司113年度股東會年報部分內容","clause":"第50款","fact_date":"2025-08-22","cite_as":"公開資訊觀測站重大訊息：益得（6461），2025-08-22 17:05，「公告補正本公司113年度股東會年報部分內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6598-2025-08-22-1700-t17v5p","company_id":"6598","company":"ABC-KY","market":"上市","industry":"生技醫療","date":"2025-08-22","time":"17:00:28","subject":"本公司受邀參加台新綜合證券舉辦之法人說明會(補充報名資訊)","clause":"第12款","fact_date":"2025-09-03","cite_as":"公開資訊觀測站重大訊息：ABC-KY（6598），2025-08-22 17:00，「本公司受邀參加台新綜合證券舉辦之法人說明會(補充報名資訊)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4128-2025-08-22-1652-e0n465","company_id":"4128","company":"中天","market":"上櫃","industry":"生技醫療","date":"2025-08-22","time":"16:52:59","subject":"公告本公司舉辦2025年第一次線上法說會事宜","clause":"第12款","fact_date":"2025-08-29","cite_as":"公開資訊觀測站重大訊息：中天（4128），2025-08-22 16:52，「公告本公司舉辦2025年第一次線上法說會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2025-08-22-1649-1b138vd","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2025-08-22","time":"16:49:12","subject":"公告本公司決定除權基準日相關事宜","clause":"第14款","fact_date":"2025-08-22","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2025-08-22 16:49，「公告本公司決定除權基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2025-08-22-1635-1q3nl0z","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2025-08-22","time":"16:35:38","subject":"公告本公司取得會計師內部控制制度專案審查報告(審查期間113/07/01-114/06/30)","clause":"第25款","fact_date":"2025-08-22","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2025-08-22 16:35，「公告本公司取得會計師內部控制制度專案審查報告(審查期間113/07/01-114/06/30)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-08-22-1549-1yksf68","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-08-22","time":"15:49:06","subject":"因應本公司上櫃申請需要委託簽證會計師出具內控專審報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-08-22 15:49，「因應本公司上櫃申請需要委託簽證會計師出具內控專審報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2025-08-22-1538-1roellr","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-22","time":"15:38:27","subject":"公告本公司董事辭任","clause":"第6款","fact_date":"2025-08-22","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2025-08-22 15:38，「公告本公司董事辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-08-22-1528-1ircp1u","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-08-22","time":"15:28:11","subject":"代重要子公司鼎晉生技公告，OBI-858新型肉毒桿菌素用於治療中重度皺眉紋之兩項第三期臨床樞紐性試驗，獲台灣衛福部食藥署(TFDA)核准執行","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-08-22 15:28，「代重要子公司鼎晉生技公告，OBI-858新型肉毒桿菌素用於治療中重度皺眉紋之兩項第三期臨床樞紐性試驗，獲台灣衛福部食藥署」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2025-08-22-1527-1w47bcb","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2025-08-22","time":"15:27:02","subject":"公告本公司114年第一次現金增資認股基準日暨相關事宜(更正原股東認購比例)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2025-08-22 15:27，「公告本公司114年第一次現金增資認股基準日暨相關事宜(更正原股東認購比例)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2025-08-22-1506-1p9501y","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2025-08-22","time":"15:06:51","subject":"公告本公司113年度股東會年報修正事宜","clause":"第50款","fact_date":"2025-08-22","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2025-08-22 15:06，「公告本公司113年度股東會年報修正事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6612-2025-08-22-1454-1kgy8xe","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2025-08-22","time":"14:54:18","subject":"公告補正本公司113年度年報部分內容","clause":"第50款","fact_date":"2025-08-22","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2025-08-22 14:54，「公告補正本公司113年度年報部分內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2025-08-22-1451-yojkdn","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2025-08-22","time":"14:51:02","subject":"公告本公司114年現金增資基準日暨相關事宜","clause":"第9款","fact_date":"2025-08-22","cite_as":"公開資訊觀測站重大訊息：普生（4117），2025-08-22 14:51，「公告本公司114年現金增資基準日暨相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2025-08-22-1431-ionxsw","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2025-08-22","time":"14:31:15","subject":"本公司受邀參加統一證券國際法人部於114年08月29日舉辦之法人說明會","clause":"第12款","fact_date":"2025-08-29","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2025-08-22 14:31，「本公司受邀參加統一證券國際法人部於114年08月29日舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6598-2025-08-22-1402-1oaynm","company_id":"6598","company":"ABC-KY","market":"上市","industry":"生技醫療","date":"2025-08-22","time":"14:02:41","subject":"本公司受邀參加台新綜合證券舉辦之法人說明會","clause":"第12款","fact_date":"2025-09-03","cite_as":"公開資訊觀測站重大訊息：ABC-KY（6598），2025-08-22 14:02，「本公司受邀參加台新綜合證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7725-2025-08-22-1141-jo8bum","company_id":"7725","company":"列特博","market":"興櫃","industry":"生技醫療","date":"2025-08-22","time":"11:41:49","subject":"本公司對子公司新增資⾦貸與達「公開發行公司資金貸與及背書保證處理準則」第22條第1項第3款規定","clause":"第20款","fact_date":"2025-08-07","cite_as":"公開資訊觀測站重大訊息：列特博（7725），2025-08-22 11:41，「本公司對子公司新增資⾦貸與達「公開發行公司資金貸與及背書保證處理準則」第22條第1項第3款規定」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1783-2025-08-22-1125-1fqkmsr","company_id":"1783","company":"和康生","market":"上市","industry":"生技醫療","date":"2025-08-22","time":"11:25:07","subject":"澄清媒體報導","clause":"第51款","fact_date":"2025-08-22","cite_as":"公開資訊觀測站重大訊息：和康生（1783），2025-08-22 11:25，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}